Clinical Trial

A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The primary object in this research study is to investigate the safety and tolerability of ZP9830 in healthy study participants, and in addition, the study will investigate how ZP9830 works in the body (pharmacokinetics, PK and pharmacodynamics, PD) compared to placebo.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-08; most recent amendment 2026-02-12.
Trial Details
NCT Number NCT06682975
Lead Sponsor Zealand Pharma
Conditions Healthy Volunteers
Enrollment 124 participants
Start Date 2024-11-12
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-17